001     134802
005     20240229105041.0
024 7 _ |a 10.3389/fimmu.2018.00701
|2 doi
024 7 _ |a WOS:000431960300001
|2 WOS
024 7 _ |a altmetric:43920426
|2 altmetric
024 7 _ |a pmid:29867918
|2 pmid
037 _ _ |a DKFZ-2018-00595
082 _ _ |a 610
100 1 _ |a Carvalho, Lina
|b 0
245 _ _ |a Reactive Oxygen Species Deficiency Due to Ncf1-Mutation Leads to Development of Adenocarcinoma and Metabolomic and Lipidomic Remodeling in a New Mouse Model of Dextran Sulfate Sodium-Induced Colitis
260 _ _ |a Lausanne
|c 2018
|b Frontiers Media
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1529307861_16578
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 317 - Translational cancer research (POF3-317)
|0 G:(DE-HGF)POF3-317
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to Web of Science, Web of Science, , CrossRef
700 1 _ |a Gomes, Joana R. M.
|b 1
700 1 _ |a Tavares, Ludgero C.
|b 2
700 1 _ |a Xavier, Ana R.
|b 3
700 1 _ |a Klika, Karel
|0 P:(DE-He78)c53db83479d3d1265967405af71f69bb
|b 4
|u dkfz
700 1 _ |a Holmdahl, Rikard
|b 5
700 1 _ |a Carvalho, Rui A.
|b 6
700 1 _ |a Souto-Carneiro, M. Margarida
|b 7
773 _ _ |a 10.3389/fimmu.2018.00701
|g Vol. 9, p. 701
|0 PERI:(DE-600)2606827-8
|p 701
|t Frontiers in immunology
|v 9
|y 2018
|x 1664-3224
909 C O |o oai:inrepo02.dkfz.de:134802
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)c53db83479d3d1265967405af71f69bb
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-317
|2 G:(DE-HGF)POF3-300
|v Translational cancer research
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT IMMUNOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b FRONT IMMUNOL : 2015
920 1 _ |0 I:(DE-He78)G404-20160331
|k G404
|l Wirkstoffforschung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G404-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21